Perioperative pharmacokinetics of factor VII concentrate during liver surgery in a patient with congenital factor VII deficiency: an individual mathematical model.
A patient with congenital factor VII deficiency (baseline activity, 7%) underwent surgery for hepatocellular carcinoma. No literature reference was found concerning the management of this coagulation defect in patients requiring liver surgery. We report one such case, with special reference to the peri-operative management of factor VII replacement therapy and the pharmacokinetic behavior of factor VII. As a result of accidental suprahepatic vein lesion, a bleeding episode occurred. This was associated with an increase in factor VII clearance and volume of distribution values from 1.30 to 3.85 l/h, and from 6.51 to 13.2 l, respectively. After surgery, the patient continued to receive the concentrate every 8 h during the first nine post-operative days. No post-operative bleeding or thrombotic event was observed. The patient was discharged in good condition.
Charpiat
B
B
Pharmacy Department, Croix-Rousse Hospital, Hospices Civils de Lyon, France.
Laporte
S
S
Mismetti
P
P
Debize
G
G
Ducerf
C
C
D000368:Aged; D016063:Blood Loss, Surgical; D006528:Carcinoma, Hepatocellular / Q000097:blood / Q000150:complications / Q000601:surgery; D005167:Factor VII / Q000493:pharmacokinetics* / Q000627:therapeutic use; D005168:Factor VII Deficiency / Q000097:blood / Q000150:complications / Q000188:drug therapy*; D006498:Hepatectomy; D006503:Hepatic Veins / Q000293:injuries; D006526:Hepatitis C / Q000150:complications; D006801:Humans; D007431:Intraoperative Complications; D008113:Liver Neoplasms / Q000097:blood / Q000150:complications / Q000601:surgery; D008297:Male; D019300:Medical Errors; D008954:Models, Biological
D005167:Factor VII